Referências:Chen, Z., Jia, H., Zhang, H. et al. Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat (2023). https://doi.org/10.1007/s10549-023-07079-8 ou https://link.springer.com/arti....cle/10.1007/s10549-0 T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li FY, Ferrucci LM, Puklin L, Cao A, Nguyen TH, Neuhouser ML, Hershman DL, Basen-Engquist K, Jones BA, Knobf T, Chagpar AB, Silber A, Tanasijevic A, Ligibel JA, Irwin ML. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. J Clin Oncol. 2023 Sep 1:JCO2300871. doi: 10.1200/JCO.23.00871. Epub ahead of print. PMID: 37656930. https://ascopubs.org/doi/10.1200/JCO.23.00871